304 related articles for article (PubMed ID: 31601536)
1. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease.
Lattanzi B; Nardelli S; Pigliacelli A; Di Cola S; Farcomeni A; D'Ambrosio D; Gioia S; Ginanni Corradini S; Lucidi C; Mennini G; Rossi M; Merli M; Riggio O
Dig Liver Dis; 2019 Nov; 51(11):1508-1512. PubMed ID: 31601536
[TBL] [Abstract][Full Text] [Related]
2. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
Bhanji RA; Moctezuma-Velazquez C; Duarte-Rojo A; Ebadi M; Ghosh S; Rose C; Montano-Loza AJ
Hepatol Int; 2018 Jul; 12(4):377-386. PubMed ID: 29881992
[TBL] [Abstract][Full Text] [Related]
3. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
[TBL] [Abstract][Full Text] [Related]
4. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
[TBL] [Abstract][Full Text] [Related]
5. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
[TBL] [Abstract][Full Text] [Related]
6. Meld-sarcopenia score and skeletal muscle density predicts short-term readmission of patients with hepatic encephalopathy.
Yang S; Zhang L; Jin Q; Wang J; Ma D; Gao J; Huang R
Eur J Radiol; 2023 Dec; 169():111178. PubMed ID: 37922620
[TBL] [Abstract][Full Text] [Related]
7. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis.
Ebadi M; Montano-Loza AJ
Dig Liver Dis; 2019 Nov; 51(11):1493-1499. PubMed ID: 31221549
[TBL] [Abstract][Full Text] [Related]
9. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
Nardelli S; Lattanzi B; Torrisi S; Greco F; Farcomeni A; Gioia S; Merli M; Riggio O
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):934-936. PubMed ID: 27816756
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts.
Nardelli S; Riggio O; Gioia S; Merli M; Spagnoli A; di Martino M; Pelle G; Ridola L
Dig Liver Dis; 2022 Aug; 54(8):1060-1065. PubMed ID: 35058135
[TBL] [Abstract][Full Text] [Related]
12. Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more?
Nardelli S; Gioia S; Ridola L; Carlin M; Cioffi AD; Merli M; Spagnoli A; Riggio O
Dig Liver Dis; 2022 Mar; 54(3):371-377. PubMed ID: 34233863
[TBL] [Abstract][Full Text] [Related]
13. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
[TBL] [Abstract][Full Text] [Related]
14. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
[TBL] [Abstract][Full Text] [Related]
15. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
[TBL] [Abstract][Full Text] [Related]
16. International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.
Hu XP; Gao J
World J Gastroenterol; 2019 Jul; 25(26):3426-3437. PubMed ID: 31341366
[TBL] [Abstract][Full Text] [Related]
17. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
18. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
[TBL] [Abstract][Full Text] [Related]
19. Muscle wasting is associated with mortality in patients with cirrhosis.
Montano-Loza AJ; Meza-Junco J; Prado CM; Lieffers JR; Baracos VE; Bain VG; Sawyer MB
Clin Gastroenterol Hepatol; 2012 Feb; 10(2):166-73, 173.e1. PubMed ID: 21893129
[TBL] [Abstract][Full Text] [Related]
20. Reply to: "May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease?" and "Has the time come for using MELD-Sarcopenia score?".
van Vugt JLA; Alferink LJM; Buettner S; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Jun; 68(6):1326. PubMed ID: 29625828
[No Abstract] [Full Text] [Related]
[Next] [New Search]